ePrivacy and GPDR Cookie Consent by TermsFeed Generator

SORAFENIB TEVA

200MG TBL FLM 28 I

SÚKL code 0227069
Name of the product SORAFENIB TEVA
_MA_MEDICATION_DETAIL_INFO_MED_NAME i SORAFENIB TEVA
Supplement 200MG TBL FLM 28 I
Strenght 200MG
Pharmaceutical form Film-coated tablet
Package 28 I
Route Oral use
Language of the pack Czech
Wrap type Blister
Legal status na lékařský předpis
Active substance SORAFENIB TOSILATE (SORAFENIBI TOSILAS)
ATC group L01EX02
ATC group name SORAFENIB

Marketing authorisation information

Registration Number 44/ 492/17-C
Type of MA A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state
MA status B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till)
Placed on the market till 31. 08. 2021
MA Holder Teva B.V., Haarlem
MA Holder country NIZOZEMSKO
Actual MA holder Teva Pharmaceuticals CR, s.r.o., Praha
Actual MA holder country ČESKÁ REPUBLIKA

Back to list